Cyagen is a 900-employee company headquartered in Santa Clara, California, with additional locations in Germany, Japan, and China. The company's slogan, "Using proven methods to bring your custom model idea to life," encapsulates its mission to provide tailored solutions for biomedical scientists' gene research needs. As the world's largest provider of custom-engineered mouse and rat models, Cyagen offers comprehensive services ranging from DNA vector construction to breeding, characterized by flexibility, top quality, full guarantees, and competitive prices. Moreover, Cyagen provides Contract Research Organization (CRO) services for cell and gene therapy (CGT) research, covering viral vector development, CAR design and construction, disease models, phenotype analysis, and pharmacodynamic evaluations. The company also offers a wide range of stem cell products for research use, including cell lines, media, and differentiation kits. With an array of services that cater to the growing demands of the biomedical research sector, Cyagen presents a compelling opportunity for venture capital firms seeking to invest in the burgeoning field of genetic research and biotechnology. The company's multi-location presence, commitment to quality, and diverse product offerings position it as an attractive prospect for potential investors looking to tap into the rapidly expanding life sciences market.
No recent news or press coverage available for Cyagen.